0001769927-19-000001.txt : 20190314
0001769927-19-000001.hdr.sgml : 20190314
20190313214559
ACCESSION NUMBER: 0001769927-19-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190314
DATE AS OF CHANGE: 20190313
EFFECTIVENESS DATE: 20190314
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Secura Bio Holdings, Inc.
CENTRAL INDEX KEY: 0001769927
IRS NUMBER: 832452762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-334812
FILM NUMBER: 19679636
BUSINESS ADDRESS:
STREET 1: 11988 EL CAMINO REAL
STREET 2: SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-251-1414
MAIL ADDRESS:
STREET 1: 1887 WHITNEY MESA DRIVE
STREET 2: #1050
CITY: HENDERSON
STATE: NV
ZIP: 89014
D
1
primary_doc.xml
X0708
D
LIVE
0001769927
Secura Bio Holdings, Inc.
11988 El Camino Real
Suite 650
San Diego
CA
CALIFORNIA
92130
858-251-1410
DELAWARE
Secura Bio, Inc.
None
Corporation
true
2018
Joseph
Limber
11988 El Camino Real
Suite 650
San Diego
CA
CALIFORNIA
92130
Executive Officer
Director
Brett
Lund
11988 El Camino Real
Suite 650
San Diego
CA
CALIFORNIA
92130
Executive Officer
Mark
Spring
11988 El Camino Real
Suite 650
San Diego
CA
CALIFORNIA
92130
Executive Officer
Juan
Estruch
11988 El Camino Real
Suite 650
San Diego
CA
CALIFORNIA
92130
Executive Officer
Jeffrey
Ferrell
Athyrium Capital Management, LP
530 Fifth Avenue, Floor 25
New York
NY
NEW YORK
10036
Director
Pharmaceuticals
No Revenues
- 06b
false
2019-02-27
false
true
true
false
0
145000000
105000000
40000000
55M represents Series A Financing of which the entire offering was sold. 90M represents a debt offering of which 50M in initial notes is outstanding and 40M remains to be issued as delayed draw notes, but there is a commitment by an investor to purchase
false
14
0
0
0
true
Certain portions of the proceeds to be used in Issuer's general operating account which will be used for compensation of employees, including executive officers
false
Secura Bio Holdings, Inc.
Mark Spring
Mark Spring
Chief Financial Officer
2019-03-13